LXRX: Lexicon Pharmaceuticals, Inc. Stock

by  •  • Comments Off on LXRX: Lexicon Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 418.60
Enterprise Value ($M) 162.88
Book Value ($M) 288.87
Book Value / Share 1.17
Price / Book 1.45
NCAV ($M) 227.25
NCAV / Share 0.92
Price / NCAV 1.84

Profitability (mra)
Return on Invested Capital (ROIC) -0.49
Return on Assets (ROA) -1.19
Return on Equity (ROE) -2.20

Liquidity (mrq)
Quick Ratio 11.26
Current Ratio 11.27

Balance Sheet (mrq) ($M)
Current Assets 355.60
Assets 417.22
Liabilities 128.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.20
Operating Income -171.75
Net Income -175.61
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -161.90
Cash from Investing -49.94
Cash from Financing 187.96

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-13 13D/A Invus, L.P. 47.70 0.00
02-14 13G/A Biotechnology Value Fund L P 9.98 51.31

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 or ☐ TRANSITION REPORT PUR
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 1,106,218 5,616,271 19.70
2024-05-02 1,343,894 4,225,436 31.80
2024-05-01 2,071,626 2,301,903 90.00
2024-04-30 1,134,617 977,842 116.03
2024-04-29 589,966 590,474 99.91

(click for more detail)

Similar Companies
KYTX – Kyverna Therapeutics, Inc. KZR – Kezar Life Sciences, Inc.
LVTX – LAVA Therapeutics N.V. LYEL – Lyell Immunopharma, Inc.
MCRB – Seres Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io